Benefits and Risks of Mammography

Women who were a mammogram are less likely to die of breast cancer, but also more chances of being found and treated a cancer that threatens their health, according to a new review of six trials involving ofWomen half a million means that for every 2,000 women who underwent mammography in a live 10 years longer with diagnosis and treatment of breast cancer, but 10 will receive unnecessary treatment, the doctors explained Peter C. Gotzsche and M. Nielsen, Nordic Cochrane Centre in Copenhagen.

"It is unclear whether the control studies help more than harm For women who were recommended such controls, they should report the risks and benefits," he wrote.

Melanoma vaccine

Hundred percent development argentinoUna melanoma vaccine ready for final test Will be tested in 108 patients with skin cancer, would be available in 3 or 4 years.

Argentine researchers have developed a vaccine to treat melanoma, the most common form of cancer in people aged between 15 and 44 years will begin in the coming months with phase studies in patients prior to approval by authorities local regulatory. If you pass this last test, called Vaccimel vaccine could be available in 3 to 4 years. "After three years of receiving the vaccine, 70% of patients in advanced stages of melanoma who participated in clinical studies so far remained free of disease," said Dr. Marcela Barrio, CONICET researcher involved in the development of Vaccimel, during a press conference held in Expo-Medical.

Treatment of neutrophils by Antonio Bru

In 1993, Doctor in Physics Antonio Bru works in the CIEMAT, the Ministry of Education and Science ...

Enjoy a contract under the project, and his work focuses on hydration fronts in heterogeneous materials, forming part of a containment of high level radioactive waste. In his paper studies the phenomena of molecular diffusion of a medium in another, and building on similarities that sometimes have physical and biological phenomena of very different nature, almost like a mathematical curiosity, became interested in the dynamics of tumor growth. He realizes that in its opinion:

Information on Neupogen

Composition: Vial: Each 1 ml vial contains: Filgrastim 30 million IU equal to 300 mcg. Preloaded Syringe: Each pre-filled syringe of 1 ml contains 30 million IU Filgrastim equal to 300 mcg ...

Therapeutic Action: Human factor granulocyte colony stimulating recombinant (Filgrastim or rHuG-CSF).

Directions: So the main uses of Neupogen (G-CSF) at present are: treatment of febrile neutropenia induced by cancer chemotherapy standard. Neupogen (G-CSF) reduces the intensity and duration of neutropenia straight to anticancer chemotherapy and reduces the incidence, duration and severity of infections that accompany the neutropenia in these patients. Treatment of neutropenia from chemotherapy with autologous bone marrow transplantation. Treatment of chronic congenital neutropenia, idiopathic, cyclic neutropenia in children and caused by radiation therapy, steroids, antiinflammatory, antithyroid drugs, AZT, and drugs in general. In patients with infection and leucopenia Neupogen can help bone marrow recovery.